| No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
| 1 |
rs10977825 |
chr9:9502055-9502056 |
Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
| 2 |
rs546927689 |
chr9:9502070-9502071 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 3 |
rs143095002 |
chr9:9502171-9502172 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 4 |
rs573778215 |
chr9:9502186-9502187 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 5 |
rs10116327 |
chr9:9502189-9502190 |
Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
| 6 |
rs552634796 |
chr9:9502197-9502198 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 7 |
rs150661029 |
chr9:9502202-9502203 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 8 |
rs544569638 |
chr9:9502203-9502204 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 9 |
rs73405068 |
chr9:9502232-9502233 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 10 |
rs576611373 |
chr9:9502249-9502250 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 11 |
rs139930228 |
chr9:9502260-9502261 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 12 |
rs112937757 |
chr9:9502270-9502271 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 13 |
rs118076441 |
chr9:9502286-9502287 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 14 |
rs537248955 |
chr9:9502306-9502307 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 15 |
rs541563339 |
chr9:9502307-9502308 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 16 |
rs10125464 |
chr9:9502309-9502310 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
| 17 |
rs183589934 |
chr9:9502327-9502328 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 18 |
rs551761641 |
chr9:9502329-9502330 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 19 |
rs115185413 |
chr9:9502348-9502349 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 20 |
rs530761747 |
chr9:9502349-9502350 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 21 |
rs149690022 |
chr9:9502378-9502379 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 22 |
rs555512039 |
chr9:9502396-9502397 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 23 |
rs187212036 |
chr9:9502422-9502423 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 24 |
rs79857465 |
chr9:9502477-9502478 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 25 |
rs145517530 |
chr9:9502478-9502479 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 26 |
rs191974309 |
chr9:9502528-9502529 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 27 |
rs570969647 |
chr9:9502540-9502541 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 28 |
rs538250911 |
chr9:9502556-9502557 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 29 |
rs556726910 |
chr9:9502577-9502578 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 30 |
rs575167126 |
chr9:9502608-9502609 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 31 |
rs112772973 |
chr9:9502624-9502625 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 32 |
rs547021925 |
chr9:9502644-9502645 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 33 |
rs574303307 |
chr9:9502736-9502737 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 34 |
rs541359344 |
chr9:9502759-9502760 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 35 |
rs541606408 |
chr9:9502781-9502782 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 36 |
rs559899397 |
chr9:9502789-9502790 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 37 |
rs182700641 |
chr9:9502799-9502800 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 38 |
rs545483208 |
chr9:9502814-9502815 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 39 |
rs116312990 |
chr9:9502818-9502819 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 40 |
rs530920243 |
chr9:9502848-9502849 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 41 |
rs549035422 |
chr9:9502910-9502911 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 42 |
rs186703633 |
chr9:9502936-9502937 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 43 |
rs528279459 |
chr9:9503000-9503001 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 44 |
rs139425401 |
chr9:9503005-9503006 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 45 |
rs375638877 |
chr9:9503010-9503011 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 46 |
rs369496974 |
chr9:9503016-9503017 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 47 |
rs538385987 |
chr9:9503045-9503046 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 48 |
rs557000306 |
chr9:9503055-9503056 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 49 |
rs568786028 |
chr9:9503065-9503066 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 50 |
rs536212891 |
chr9:9503087-9503088 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
Variant related diseases (count:112)
